After Omicron, can we learn to live with the
coronavirus?
Some scientists say the current surge of infection
heralds a transition to a new, less dangerous, ‘endemic’ phase — but the coming
weeks will be tough.
BY CARLO
MARTUSCELLI, ASHLEIGH FURLONG AND HELEN COLLIS
January 5,
2022 3:27 pm
https://www.politico.eu/article/after-omicron-variant-can-we-learn-to-live-with-coronavirus-covid19/
The Omicron
variant is driving an unprecendented wave of coronavirus infection in Europe
that, because it is so contagious, means it will be hard for most people to
avoid exposure to the disease.
Even if Omicron
is less deadly than earlier versions of the Sars-CoV-2 virus, hospitals and
other critical services still face enormous strains in the weeks ahead as staff
are infected or have to isolate.
But what
happens then? Some scientists say that the current surge heralds an "exit
wave" from the two-year-old pandemic and a transition to a new, less
dangerous, endemic phase where societies will have to learn to live with the
virus. Others call this wishful thinking and warn that, with more people infected
than ever, risks will only grow of a new, and more dangerous, strain emerging:
How big
will the Omicron wave be?
The Omicron
wave has been compared by political leaders to a tidal wave: France reached a
dizzying 270,000 new cases on Tuesday, while countries including Greece, Italy,
and Spain are also setting infection records. Eastern European countries are
now detecting their first Omicron cases.
But health
experts agree that, unlike this time last year, intensive care units aren't at
risk of being overrun. While Omicron can sidestep prior immunity, studies point
to vaccines and previous infections still protecting against the worst
outcomes.
In the U.K.
— the first country in Europe to encounter Omicron — new infections crossed the
threshold of 200,000 on Tuesday and hospitalizations are increasing. But the
number of patients being mechanically ventilated remains flat despite the surge
in infections. That's a positive signal for the rest of Europe.
How bad
will it be?
Omicron is
capable of dodging immunity from a standard course of vaccination or prior
infection with COVID-19. But, importantly, booster shots appear to be effective
and Omicron itself is less dangerous than earlier variants. Research points to
the variant concentrating in the upper airways, avoiding the more sensitive
lungs previously linked with fatal complications from COVID-19.
Despite the
variant's lesser virulence and widespread immunity from vaccines, health
systems are still under pressure. In Italy, patients are filling regular
hospital beds even if they don't end up in the ICU, said Fidelia Cascini,
assistant professor of public health at the Università Cattolica Sacro Cuore in
Rome. This means drawing on resources that could be used for other patients in
health systems already struggling with backlogs and staff shortages.
More
broadly, mass absences when staff have to isolate after testing positive could
threaten essential services and critical infrastructure, and undermine the
continent's fragile economic recovery from recent lockdowns.
Sarah
Scobie, deputy director of research at the health-focused think tank Nuffield
Trust, said that 25,000 U.K. health care workers were off sick in the most
recent week for which data is available. In England, several hospital trusts
have declared "critical incidents" due to staff shortages. The full
impact of Omicron remains to be seen, Scobie cautioned, since it is only now
starting to spread among the elderly, who are more likely to become severely
ill from the coronavirus.
When will
it end?
Flemming
Konradsen, professor of global environmental health at the University of
Copenhagen, expects Europe to be in a very different place by the end of
February. In Denmark, the first country on the continent to record a major
Omicron wave, the variant's rapid spread means that it will run through the
population quickly.
"After
the burnout, we'll have a population in Denmark that is close to 90 percent
infected or immunized. And that, of course, will make the disease quite
different," said Konradsen. People will still get sick but the risk of
serious illness will concentrate in settings such as nursing homes and
hospitals.
This
scenario is likely to play out across Europe, as the rollout of booster shots
and immunity gained through infection with Omicron improves the population's
defenses. Eastern Europe, where vaccination levels lag, could be vulnerable:
"I would expect that many health systems across Europe during the month of
January into mid-February would be put under significant pressure," said
Konradsen.
Is South
Africa the future?
South
Africa was one of the first countries to detect the Omicron variant in late
November. Public health experts have since analyzed the Omicron wave to
understand how the variant might spread around the world.
With its
young demographic profile, the African nation isn't a perfect parallel to
anywhere in Europe. Still, cases have already peaked without a large increase
in deaths. And, in contrast to earlier waves, South Africa held off from
imposing further restrictions even as Omicron surged. So far, that approach has
paid off.
“We
basically made a strong case that going to higher levels of restrictions should
be only informed if healthcare facilities were imminently under threat and not
based on the increasing number of cases,” said Shabir Madhi, professor of
vaccinology at the University of the Witwatersrand and chair of the National
Advisory Group on Immunization in South Africa. “It worked extremely well, with
minimum damage in South Africa compared to what happened in the past.”
Going
forward, the focus needs to be on preventing severe disease and death, said
Madhi. “By continuously harping on about the number of people that have been
infected, it's really missing the point that the virus is not going to
disappear,” he said.
Can we
learn to live with the virus?
Scientists
are starting to speak of a possible end to the pandemic, with the virus
becoming "endemic," circulating freely but posing less of a threat to
societies.
That's the
view of epidemiologist Maria Van Kerkhove, the World Health Organization’s
technical lead on COVID-19. Speaking in December, she predicted a long
transition before the end of the pandemic. “Endemic doesn't mean that it's not
dangerous,” Van Kerkhove added.
But there
is no consensus on just how the pandemic will evolve, or even what living with
an endemic virus will be like.
Masks, for
example, are likely to remain a common feature in Europe, as they already were
in Asia throughout the flu season, said Martin McKee, professor of public
health at the London School of Hygiene & Tropical Medicine.
He’s a
signatory of a letter co-authored by a number of different public health
experts advocating for a “vaccine plus” strategy that focuses both on jabs and
public health measures, including tighter restrictions if needed. McKee said
the focus should continue to be on suppressing the virus, which can still pose
a risk for the most vulnerable.
Could a
more deadly variant emerge?
McKee
warned, however, that there is no scientific consensus on whether the
coronavirus will remain less deadly: It could continue to evolve and again
become more dangerous. A group of Swedish-based scientists shares that fear:
"Letting large amounts of infection circulate is like opening Pandora’s
box. We should expect more unpleasant surprises to come. We have hardly seen
the last variant," they wrote in an opinion piece for POLITICO.
David
Heymann, professor of infectious disease epidemiology at the London School of
Hygiene & Tropical Medicine, agreed that there was always the chance of a
dangerous mutation. But, he added, the high level of population immunity
reached in the U.K. should guide a different approach. Rather than top-down
decisions like lockdowns, people should perform their own risk assessments. For
example, testing themselves before going out to dinner, or avoiding vulnerable
people if there might be a risk of infection.
"It's
a matter of just letting this disease become like other diseases, one that we
do our own assessment on," he said. "Let's get on with doing what we
need to do to prevent this from rapidly spreading and to protect others."
This
article is part of POLITICO’s premium policy service: Pro Health Care. From
drug pricing, EMA, vaccines, pharma and more, our specialized journalists keep
you on top of the topics driving the health care policy agenda. Email
pro@politico.eu for a complimentary trial.
Sem comentários:
Enviar um comentário